RRA analysis further identify a set of MSI1-bound genes in G3 MB, including TMEM33, SFNX and HIPK1, as cancer-selective downstream targets for therapeutic drug targeting (i.e., not bound in NSC) (Fig. 4b left panel, Supplementary Fig. 9a). The gene discussed is HIPK1; the disease is cancer.